Beacon Biomedical, Inc., a privately held company focused on developing highly accurate laboratory and point-of-care blood tests for colorectal cancer screening and its early detection, has opened new Corporate Offices and their R&D-CLIA laboratory at the Center for Entrepreneurial Innovation (CEI) in Phoenix.
Don We
ber, CEO of Beacon, stated, “We are thrilled to be opening our offices and laboratory at the Center for Entrepreneurial Innovation (CEI) here in Phoenix. We are now one step closer to reaching our goal of having an easy, accurate and affordable blood-based colorectal cancer screening test available to healthcare providers and their patients by year end.”
Thomas Schumann, Executive Director of the Center for Entrepreneurial Innovation, added, “We are very pleased that Beacon Biomedical chose the Center for Entrepreneurial Innovation for their Laboratory. Their screening technologies that allow for an earlier detection of cancers promise to save lives and will have a measurable impact on healthcare costs. Working together we hope to accelerate their success in the marketplace.”
Beacon’s laboratory buildout provides both the R&D and CLIA capabilities needed to both ramp-up additional/new IP generation and the production capacity to support up to 125,000 tests per year ($9.3 MM Sales) following the October Laboratory Developed Test (LDT) launch
A division of the Maricopa Corporate College, the Center for Entrepreneurial Innovation is a community-based business incubator located in the heart of Discovery Triangle. With funding from the US Economic Development Administration, City of Phoenix and Maricopa County Community College District, CEI provides targeted business services and proactive business support to create a systematic link between technology development, compelling markets and opportunities;